Jan 27, 2014 01:59 PM EST
LABA Drugs for Asthma May Negatively Impact People With Rare Genetic Variations
Asthma affects more than 25 million people in the United States. Long-acting beta agonists (LABAs) are the most common drugs to treat the lung disease, but they may cause life-threatening side effects within a small subgroup of asthma patients, a recent study revealed.